Review of Efficacy of Baricitinib in the Treatment of Alopecia Areata
April 2023
in “
International Journal of Research in Dermatology
”
TLDR Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.
The review paper discusses the efficacy of Baricitinib, a first-generation Janus kinase (JAK) inhibitor, in treating Alopecia Areata (AA), an autoimmune condition causing patchy, non-scarring hair loss. The authors conducted a comprehensive review of research papers published from 2010-2022, focusing on the use of Baricitinib for AA treatment. The findings suggest that the use of Baricitinib for severe AA in multiple studies generally led to an improvement in patients' conditions with minimal side effects. This indicates that Baricitinib could be a promising treatment for AA.